Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from Revision: v3.6.0 to Revision: v3.6.3, indicating a backend or UI update rather than a change to the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded the study's responsible party name (Luis F. Lopez-Cortes) and status indicators (Last verified; Last known status was), along with new navigation links (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized Intervention/Treatment label with a revision update to v3.6.0. The previous items and formatting (Last known status was; Verified; Luis F. Lopez-Cortes; Hospitales Universitarios Virgen del Rocío; Intervention / Treatment; Revision: v3.5.5) were removed or reformatted.SummaryDifference2%

- Check23 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor page/configuration update.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a newer version of the page; the previous revision indicator has been replaced to reflect the update.SummaryDifference0.1%

- Check66 days agoChange DetectedClinicalTrials.gov updated the page’s displayed software/version revision from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.